ME Research UK: Our autumn issue of Breakthrough magazine is now available to read online and download. It features an overview of all our most recently funded research projects, as well as a feature on the DHSC interim delivery plan, an article from Cort Johnson on the role of small funders like us, and much more. Read it here: https://www.meresearch.org.uk/research/breakthrough-magazine/
ME Research UK – October 2023 e-newsletter https://www.meresearch.org.uk/me-research-uk-october-2023-e-newsletter/
ME Research UK is delighted to announce that we have awarded funding to Dr Zack Shan at the University of the Sunshine Coast for a new study using MRI to assess brain neuroinflammation and the lymphatic system in ME/CFS. Dr Shan and his colleagues are conducting the world’s first controlled study directly assessing neuroinflammation in the brains of people with ME/CFS. They plan to investigate the characteristics of brain immune cells and the lymphatic network, in order to understand more about the role of neuroinflammation in ME/CFS and whether this might help in the development of evidence-based treatments. Read more: https://meres.uk/shan062 More detailed description: https://meres.uk/shan062info
Tying in with last week's announcement of a new study assessing brain neuroinflammation, Cort Johnson takes a look at some of the ways in which the brain may be involved in ME/CFS, and recent research aiming to explore this further. Read more: https://www.meresearch.org.uk/is-the-answer-to-me-cfs-in-the-brain/
I'm sorry to see MERUK posting an article that gives the same credibility to serious scientific studies and a the quack Perrin technique based on a single study with no control group, unblinded with subjective outcomes done on pwLC who were early enough in their post Covid symptoms to be likely to recover anyway.
ME Research UK is delighted to announce that we have awarded funding to Dr Jo Nijs at Vrije Universiteit Brussel in Belgium, for new PhD-level research exploring the links between mitochondrial function and the autonomic nervous system in ME/CFS. The team includes Dr Andrea Polli, Dr Jolien Hendrix, and PhD student Jente Van Campenhout, who will compare mitochondrial function between groups of ME/CFS patients divided according to the autonomic symptoms they experience. As well as understanding the disease process better, subgrouping patients could help improve diagnosis and selecting treatments. @paininmotion Read more: https://bit.ly/nijs004 More detailed description: https://bit.ly/nijs004info
I think there's a lot to like about this study. It's worth clicking through to the fuller explanation, which is still just a summary. One thing is this - the Fred and Joan Davies Bequest. I haven't heard of it, but it is really lovely that people cared enough to donate money in a bequest. Also that MERUK description at the link is clear and you can choose to listen to it rather than read it. At first I was worried that they would classify people on the basis of whether they had various autonomic (orthostatic, gastrointestinal) symptoms at one point in time. Symptoms change from day to day, so I thought the research might just get confounded by short term variation. But, they are tracking measures across two visits, before and after exercise and a standing test. So perhaps they can identify some real differences. 75 people is a good sized study. And they are tracking PEM, so the study might tell us something about that. I like that they have a hypothesis about methyltransferase activity and will look for that. I didn't see what sampling they would do, I assume it's a blood sample, so then what cells would they be looking at and are they active? Or maybe it's a muscle biopsy? That would be my main concern with this study - are they sampling the right cells, and are the procedures for measuring mitochondrial function good enough (e.g. measuring quickly enough after sample collection). I also like that Jente fronted up to give a description of her project, and in English too, thank you. It would be great if she visited the forum, we have some other relatively young researchers investigating mitochondrial function already here.
From ME Research UK: Today is International Men’s Day. Read more about ME/CFS in men, and the challenges men with the disease face on our website: https://bit.ly/imd2023a
Differences between men & women with ME/CFS – what does the evidence say? 19 November 2023 https://www.meresearch.org.uk/differences-between-men-women-with-me-cfs-what-does-the-evidence-say/
So interesting to look at the biological findings of differences the between men and women here. I was really interested by Decode MEs results, when they returned the preliminary results showing how the symptom patterns taken from averages diverged so much. I often wonder too about trans people with ME, of whom there must be a few out there, who’ve taken hormones in either direction, and whether current hormone levels are influencing the progression or remission of ME or not really. Are hormones an ongoing risk or protective factor for the course of disease once you have it, or is it just a matter of certain hormone levels putting you at risk at certain points. My guess is hormones are a significant vulnerability. But perhaps not the most important factor. Otherwise I guess even fewer men would get sick than do. I’m betting hormones can be protective but only to a certain extent. The CFS questionnaire for testing five mens attitudes is a disappointment. But it is a CFS study so to be expected I guess.
The ME Association and ME Research UK announce funding for a study that aims to create a diagnostic test for ME/CFS See this thread: https://www.s4me.info/threads/the-n...ned-on-the-lab-bench.34019/page-4#post-501131
ME Research UK ME Research UK is delighted to announce that we have awarded funding to Dr Douglas Barrett at Leicester University for new PhD-level research exploring visual problems in ME/CFS. The team includes Dr Claire Hutchinson, Dr David Souto and PhD student Anosha Atlaf, who will conduct various tests of visual sensitivity, selective attention and target detection in ME/CFS patients and healthy control subjects, and measure related markers of behaviour, eye movement and nerve activity. As well as understanding more about the impact of ME/CFS on visual function, the results may provide diagnostic markers of the disease. Read more: https://www.meresearch.org.uk/research/barrett-phd005 Read a more detailed description: https://www.meresearch.org.uk/research/barrett-phd005-info
ME Research UK and Daphne Jackson Trust launch ME/CFS Fellowship Applications are invited for a three-year Daphne Jackson Fellowship co-sponsored by ME Research UK. The Fellowship is open to talented researchers with a PhD – likely in a life science e.g. biomedical sciences, whole organismal biology, molecular genetics, infection and microbiology, structural biology, biological chemistry, who wish to return to research within a UK university or research institution after a career break of two or more years. https://www.meresearch.org.uk/me-research-uk-and-daphne-jackson-trust-launch-me-cfs-fellowship/ Chris Ponting on Twitter writes "I'd be delighted to sponsor a @MEResearchUK and @DaphneJacksonTr #MEcfs Fellowship in @EdinburghUni (closing data 4 March 2024). Please get in touch"
ME Research UK and the ME Association have announced funding for a study that aims to create a diagnostic test for ME/CFS. This 12-month study will build upon initial findings of white blood cell impedance in the disease by using improved methods in a larger cohort, in the hope that it will result in a reliable, repeatable, and low-cost diagnostic tool using the electrical signature from a simple blood test. Read more: https://www.meresearch.org.uk/me-re...-aims-to-create-a-diagnostic-test-for-me-cfs/ “Both our group and the Davis group have identified electrical variations in ME/CFS cells compared to healthy controls. This is itself highly significant, representing a clear marker of pathology.”
ME Research UK – February 2024 e-newsletter https://www.meresearch.org.uk/me-research-uk-february-2024-e-newsletter/
ME Research UK – March 2024 e-newsletter https://www.meresearch.org.uk/me-research-uk-march-2024-e-newsletter/
A Griffith University research team has successfully applied for a $438,000 ME Research UK grant to track the progression of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://news.griffith.edu.au/2024/04/11/me-cfs-progression-in-focus-with-438000-grant/ A Griffith University research team has successfully applied for a $438,000 ME Research UK grant to track the progression of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The study will use an ultra-high field 7 Tesla (7T) MRI to capture a clearer depiction of brain regions and detect subtle brain changes in ME/CFS patients.
ME Research UK: PhD candidate Tina Katsaros – who is working alongside her supervisor Dr Sarah Annesley on a project funded by ME Research UK, has spoken about her research on an Australian radio show called “Einstein A GO-Go” (Triple R - 3RRR 102.7FM). The show aims to explore “the wonders of science and its impact on the world”, and in this specific episode, the host heard from 20 different PhD students in 20 minutes. In the time allocated to her, Tina not only discussed her PhD study entitled “Cause-effect relationships in the mitochondrial energy inefficiency in ME/CFS”, but also highlighted the complexity of ME/CFS, and delays in the diagnostic process experienced by many people with the disease. Listen to Tina talk about her project : https://bit.ly/49XMtQv More information about the ME Research UK funded research Tina is working upon can be found on our website: https://meres.uk/LaTrobePhD
ME Research UK: Our Fundraising Focus highlighting upcoming fundraising events by wonderful supporters this month is now available on our website - https://www.meresearch.org.uk/fundraising-focus-april-2024/ From Walk for ME to #bluesunday2024 & even an online raffle for handcrafted and unique items! #pwME #MECFS